Toward a personalized approach to the study and treatment of bone cancers

by Lund UniversityPrimary acute myeloid leukemia cells preferentially home and engraft in MSOD-B hOss.a, Experimental scheme of AML patient sample transplantation. b, Representative histological

Updated on: February 20,2024

Toward a personalized approach to the study and treatment of bone cancers

by Lund UniversityPrimary acute myeloid leukemia cells preferentially home and engraft in MSOD-B hOss.a, Experimental scheme of AML patient sample transplantation. b, Representative histological

Updated on:February 20,2024

Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainThe Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, c

Updated on: January 28,2024

Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainThe Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, c

Updated on:January 28,2024

Surveillance colonoscopy rarely IDs cancer in older adults, study finds

by Lori SolomonColorectal cancer (CRC) is rarely detected from surveillance colonoscopy among older adults, regardless of prior adenoma findings, according to astudypublished online April

Updated on: April 06,2024

Surveillance colonoscopy rarely IDs cancer in older adults, study finds

by Lori SolomonColorectal cancer (CRC) is rarely detected from surveillance colonoscopy among older adults, regardless of prior adenoma findings, according to astudypublished online April

Updated on:April 06,2024

One lung cancer drug receives NHS England approval, while another is rejected

by Cancer Research UKCredit: CC0 Public DomainA targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision d

Updated on: May 20,2024

One lung cancer drug receives NHS England approval, while another is rejected

by Cancer Research UKCredit: CC0 Public DomainA targeted drug has been accepted for routine use on the NHS in England for some adults with untreated, advanced lung cancer. But another precision d

Updated on:May 20,2024

Blood test for deadly eye melanoma

by University of QueenslandCredit: CC0 Public DomainA simple blood test could soon become the latest monitoring tool for the early detection of melanoma in the eye.University of Queensland scient

Updated on: March 30,2024

Blood test for deadly eye melanoma

by University of QueenslandCredit: CC0 Public DomainA simple blood test could soon become the latest monitoring tool for the early detection of melanoma in the eye.University of Queensland scient

Updated on:March 30,2024

Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

by University of HelsinkiSchematics showing the overview of data sets, analysis, and validation and extensions. Picture created with biorender.com. Credit:Leukemia(2023). DOI: 10.1038

Updated on: April 18,2024

Boosting immune system in chronic myeloid leukemia may lead to discontinuation of blood cancer drugs

by University of HelsinkiSchematics showing the overview of data sets, analysis, and validation and extensions. Picture created with biorender.com. Credit:Leukemia(2023). DOI: 10.1038

Updated on:April 18,2024

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Updated on: August 28,2024

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Updated on:August 28,2024

Combo immunotherapy produces distinct waves of cancer-fighting T cells with each dose

byPerelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainA new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor

Updated on: September 07,2024

Combo immunotherapy produces distinct waves of cancer-fighting T cells with each dose

byPerelman School of Medicine at the University of PennsylvaniaCredit: CC0 Public DomainA new tool for monitoring immune health patterns over time has revealed how a pair of checkpoint inhibitor

Updated on:September 07,2024

Researchers discover the mechanism by which tumor cells become resistant to chemotherapy in colorectal cancer

by Institute for Research in Biomedicine (IRB Barcelona)Oxaliplatin accumulation in the tumor microenvironment of a patient with colon cancer 44 days after treatment. Credit: IMIMPlatinum-based c

Updated on: February 23,2024

Researchers discover the mechanism by which tumor cells become resistant to chemotherapy in colorectal cancer

by Institute for Research in Biomedicine (IRB Barcelona)Oxaliplatin accumulation in the tumor microenvironment of a patient with colon cancer 44 days after treatment. Credit: IMIMPlatinum-based c

Updated on:February 23,2024

Shedding light—literally—on resistance to radiation therapy

by Johns Hopkins UniversityCredit: CC0 Public DomainA new Johns Hopkins study offers promise towards someday being able to non-invasively examine changes in cancerous tumors to determine whether

Updated on: March 12,2024

Shedding light—literally—on resistance to radiation therapy

by Johns Hopkins UniversityCredit: CC0 Public DomainA new Johns Hopkins study offers promise towards someday being able to non-invasively examine changes in cancerous tumors to determine whether

Updated on:March 12,2024

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea

Updated on: September 27,2024

Leveraging the power of iPS cell technology to study myeloid neoplasm

byKyoto UniversityCredit:British Journal of Haematology(2024). DOI: 10.1111/bjh.19720Using iPS cells generated from a patient with a myeloid neoplasm caused by a rare chromosomal rea

Updated on:September 27,2024

Researchers revisit potent drug as promising treatment for acute leukemia

by National University of SingaporeChemical screening using the GIMAP enhancer reporter system. (A) Overview of the chemical screening strategy. Using a liquid handling workstation, 2,961 compoun

Updated on: February 03,2024

Researchers revisit potent drug as promising treatment for acute leukemia

by National University of SingaporeChemical screening using the GIMAP enhancer reporter system. (A) Overview of the chemical screening strategy. Using a liquid handling workstation, 2,961 compoun

Updated on:February 03,2024